Cenforce-D (sildenafil + dapoxetine)
Cenforce-D is recorded as a combination of sildenafil 100 mg and dapoxetine 60 mg attributed to Centurion Laboratories.
- Active ingredient
- sildenafil + dapoxetine
- Formulation
- Oral tablet
- Company in catalogue
- Centurion Laboratories Pvt Ltd
Cenforce-D is recorded as a combination of sildenafil 100 mg and dapoxetine 60 mg attributed to Centurion Laboratories. The D suffix distinguishes it from the single-ingredient Cenforce tablet family.
What distinguishes this product
The two component amounts must remain attached to their respective ingredients. Dapoxetine concerns premature ejaculation, whereas sildenafil concerns erectile function; a product combining them needs separate assessment of the combination, not just recognition of the Cenforce name.
Product record
- Record type
- Indian branded generic
- Treatment area in this directory
- Erectile dysfunction (ED); Premature ejaculation (PE)
- Active ingredient
- sildenafildapoxetine
- Formulation in the cited record
- Oral tablet
- Source-listed strengths
- Sildenafil 100 mg + Dapoxetine 60 mg
- Company in the cited record
- Centurion Laboratories Pvt Ltd (Company attributed by the source catalogue)
- Manufacturing information
- A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
- Market evidence
- Global reference; exact market authorization not established by this catalogue import
- Storage reported by source
- Store below 30°C Check the supplied leaflet for the exact presentation.
- Catalogue reviewed
Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.
Component amounts in the source
- sildenafil: 100 mg
- dapoxetine: 60 mg
Ingredient references
These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.
How the ingredients fit treatment
Sildenafil supports the erection response to sexual stimulation by inhibiting PDE5. It is used before sexual activity in ED treatment; it is not a libido stimulant. Food can affect the response, so use the instructions for the prescribed presentation.
Dapoxetine addresses premature ejaculation. Its presence alongside an ED ingredient creates a separate combination-treatment question; consult the dapoxetine guidance and the exact product information.
Ingredient guidance and safe use
Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.
Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.
Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.
A fixed combination needs assessment of every ingredient and their use together. Approval of either ingredient separately does not establish that the combination is suitable. Do not add another ED medicine to it without medical advice.
Tell the prescriber about antidepressants and other medicines affecting serotonin. Do not start, stop or change an existing antidepressant prescription to fit an ED combination product.
Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record